本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Prime Medicine, Inc.

2.01
+0.01000.50%
盤後1.96-0.0500-2.49%19:39 EDT
成交量:206.40萬
成交額:428.49萬
市值:2.57億
市盈率:-1.22
高:2.30
開:2.06
低:1.94
收:2.00
資料載入中...

公司資料

公司名字:
Prime Medicine, Inc.
交易所:
NASDAQ
成立時間:
2019
員工人數:
214
公司地址:
21 Erie Street,Cambridge,Massachusetts,United States
郵編:
02139
電話:
傳真:
- -
簡介:
Prime Medicine, Inc.於2019年9月在特拉華州註冊成立。該公司是一家生物技術公司,致力於提供一類新的差異化一次性治療基因療法— Prime Editors,通過部署Prime Editing技術來解決最廣泛的疾病譜。

董事

名稱
職位
Keith Gottesdiener
President, Chief Executive Officer and Director
David Schenkein
Director
Kaye Foster
Director
Michael Kelly
Director
Robert Taylor NELSEN
Director
Thomas Cahill
Director
Wendy Chung
Director

股東

名稱
職位
Keith Gottesdiener
President, Chief Executive Officer and Director
Carman Alenson
Interim Chief Financial Officer and Chief Accounting Officer
Meredith Goldwasser
Senior Vice President, Strategy and Corporate Operations
Andrew Anzalone
Senior Scientist II, Head of Prime Editing Platform
Ann Lee
Chief Technical Officer
Jeremy Duffield
Chief Scientific Officer
Richard Brudnick
Chief Business Officer